Log In
BCIQ
Print this Print this
 

GSK1070916, GSK1070916A, NMI-900

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionInhibitor of aurora kinase B (AURKB; Aurora-B) and AURKC
Molecular Target Aurora kinase B (AURKB) (Aurora-B) ; Aurora kinase C (AURKC) (Aurora-C)
Mechanism of Action 
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/07/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today